Trial
NCT02264288
Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Celularity Incorporated
Collaborators
—
Condition
Peripheral Arterial Disease
Intervention
PDA-002
Why stopped
The study was terminated early due to a business decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-12